| DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) (NCT00302341) | Immtech Pharmaceuticals, Inc | 2006-05-01 |
| A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols (NCT00000784) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-10-01 |
| A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies (NCT00001016) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients (NCT00000730) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia (NCT00001991) | Glaxo Wellcome | |
| Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects (NCT00000740) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC) (NCT00002043) | Jacobus Pharmaceutical | |
| Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii Pneumonia (NCT00002120) | U.S. Bioscience | |
| A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / Trimethoprim in the Treatment of Mild-to-Moderate PCP in Patients With AIDS (NCT00000640) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection (NCT00000739) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00002292) | LyphoMed | |
| A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCP (NCT00002055) | Fisons | |
| A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia in AIDS (NCT00000715) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole (NCT00001996) | Glaxo Wellcome | |
| A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX (NCT00002340) | Glaxo Wellcome | |
| A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children (NCT00000811) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients (NCT00002030) | Fisons | |
| A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients (NCT00000748) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP) (NCT00002434) | U.S. Bioscience | |
| Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine Therapy (NCT00000722) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia. (NCT00002102) | U.S. Bioscience | |
| Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00001013) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii Pneumonia (NCT00000724) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children (NCT00000773) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection (NCT00005572) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00002283) | Jacobus Pharmaceutical | |
| A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell Counts (NCT00000908) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDS (NCT00002056) | LyphoMed | |
| A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia (NCT00002317) | U.S. Bioscience | |
| An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia (PCP) and Serious Intolerance to Approved Therapies (NCT00000714) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS (NCT00001014) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP (NCT00000998) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides (NCT00001028) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii Pneumonia (NCT00002103) | U.S. Bioscience | |
| A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients (NCT00000863) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia (NCT00000974) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients (NCT00002054) | Fisons | |
| Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis (NCT00000816) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before (NCT00002291) | Fisons | |
| An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine (NCT00001990) | Glaxo Wellcome | |
| A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides (NCT00000802) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (NCT00001003) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients (NCT00000991) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients (NCT00000655) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) (NCT00000727) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of Aerosolized Pentamidine as Treatment of Subclinical Pneumocystis Infection in Patients With No Clinical Symptoms (NCT00000707) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS (NCT00000741) | National Institute of Allergy and Infectious Diseases (NIAID) | |